ProCE Banner Activity

CCO Think Tank on Emerging HER2-Targeted ADCs: Genitourinary Malignancies

Slideset

Slides from Elizabeth Plimack, MD, covering the recent developments in HER2 testing, clinical trial results for anti-HER2 antibody-drug conjugate (ADC) therapy, and current strategies on managing the safety profile of ADCs.

Released: March 22, 2024

Expiration: March 21, 2025

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca and Daiichi Sankyo, Inc.

AstraZeneca

Daiichi Sankyo, Inc.